Amedisys Inc.
AMED
Market Cap$3.13B
Close$
$103.59
9.5% upside
Current Fair Value
9.5% upsideUndervalued by 9.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.13 Billion |
|---|---|
| Enterprise Value | $3.30 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $1.32 |
| Beta | 0.97 |
| Outstanding Shares | 32,793,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 27.32 |
|---|---|
| PEG | 8.44 |
| Price to Sales | 1.31 |
| Price to Book Ratio | 2.56 |
| Enterprise Value to Revenue | 1.39 |
| Enterprise Value to EBIT | 22.9 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.38 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Amedisys Inc.
CEO: Paul Kusserow